BeStock  
Stocks › Biotechnology › AVBP

ArriVent BioPharma AVBP

US equityMarket cap rank #3544Biotechnology
$10.52 −$0.74 (-6.57%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $10.52 0.00%
Open$11.00
Prev close$11.26
Day range$10.38 – $11.35
Volume1.05M
Market cap$544.13M
P/E (TTM)–
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings-3.6x
CheapRich

Near the top of its 5-year range · 99th percentile, 5-year average -8.1x

Price / book1.7x
CheapRich

Near the bottom of its 5-year range · 11th percentile, 5-year average 2.4x

#2750 of 5330 stocks by PB (1 = cheapest)

Price / sales134.6x
CheapRich

Near the top of its 5-year range · 99th percentile, 5-year average 1.0x

#4980 of 5155 stocks by PS (1 = cheapest)

P/E over five years

-17x-11x-5x1xJan '24Jun '25Nov '26

Dashed line is the 5-year average; the shaded band is one standard deviation either side.

Morningstar fair value estimate

Fair value$18.09
Price vs. fair value-41.8%Trading below the estimate
Star rating★★★☆☆
Economic moatNone
UncertaintyVery High
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB 1.71 – 2.42 11% (cheaper than usual) #2750 of 5330 (1 = cheapest)
PE -3.61 -3.40 -8.08 99% (pricier than usual) –
PS 134.58 73.51 0.98 99% (pricier than usual) #4980 of 5155 (1 = cheapest)

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Discussion

No comments yet — be the first to weigh in on AVBP.

Sign in to join the discussion.

Scroll to Top